Drug profile · INN
tretinoin
TRETINOIN
tretinoin (TRETINOIN) is a retinoic acid receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: topical. Current US regulatory status: approved.
Drug details — tretinoin
- US status
- approved
- Class
- —
- Route
- TOPICAL
- Patents
- 4
- Programs
- 32
- Data quality
- 0.89
Quick answer
tretinoin (TRETINOIN) is a retinoic acid receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: topical. Current US regulatory status: approved.
Key facts
Mechanism of action
Retinoic acid receptor agonist
Primary target: Retinoic acid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is tretinoin?
tretinoin (TRETINOIN) is a retinoic acid receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for tretinoin?
TRETINOIN is a marketed brand name for tretinoin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of tretinoin?
tretinoin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.